Niharika Mallepally
Overview
Explore the profile of Niharika Mallepally including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wenker T, Peng F, Emelogu I, Mallepally N, Kanwal F, El-Serag H, et al.
Clin Gastroenterol Hepatol
. 2022 Oct;
21(7):1771-1780.
PMID: 36270616
Background: The Houston Consensus Conference and American College of Gastroenterology (ACG) have recommended Helicobacter pylori screening in United States populations with specific risk factors. However, the performance of these guidelines...
2.
Tan M, Mallepally N, Nguyen T, Hammad T, Kim D, Othman M, et al.
Dig Dis Sci
. 2022 Jun;
68(3):761-769.
PMID: 35689702
Background: Screening for gastric cancer is not recommended despite rising rates in certain U.S. Populations: We determined possible missed opportunities for the detection and surveillance of preneoplastic lesions among gastric...
3.
Deng N, Mallepally N, Peng F, Kanji A, Marcelli M, Hernaez R
Liver Int
. 2021 May;
41(10):2358-2370.
PMID: 33966337
Background & Aims: Cirrhosis disrupts the hypothalamic-pituitary-gonadal axis causing low testosterone. Testosterone deficiency is associated with sarcopenia and osteopenia, leading to a state of frailty and worse clinical outcomes, morbidity...
4.
Nguyen C, Mallepally N, Tabilona J, Lu L
J Gen Intern Med
. 2021 Jan;
36(4):1102-1105.
PMID: 33469775
No abstract available.
5.
Mallepally N, Bilal M, Hernandez-Barco Y, Simons M, Berzin T, Oxentenko A
Dig Dis Sci
. 2020 Jul;
65(8):2164-2168.
PMID: 32613594
No abstract available.
6.
Tan M, Mallepally N, Ho Q, Liu Y, El-Serag H, Thrift A
Dig Dis Sci
. 2020 Jun;
66(5):1600-1610.
PMID: 32535778
Background: Studies on diet and gastric intestinal metaplasia (GIM) risk are lacking in US populations. Aim: To determine the associations of dietary factors and risk of GIM among a US...
7.
Abu-Sbeih H, Mallepally N, Goldstein R, Chen E, Tang T, Dike U, et al.
J Cancer
. 2020 Apr;
11(11):3144-3150.
PMID: 32231718
: Platinum-based therapy (PBT) can be limited by gastrointestinal adverse events, particularly PBT-related colitis and diarrhea (PCD). We studied clinical features, treatments, and outcomes of PCD. : This was a...
8.
Tan M, Mallepally N, Liu Y, El-Serag H, Thrift A
Am J Gastroenterol
. 2020 Jan;
115(3):381-387.
PMID: 31899705
Objectives: The risk of noncardia gastric cancer is increased in the presence of gastric intestinal metaplasia. We aimed to identify demographic and lifestyle factors independently associated with the risk of...
9.
Chen E, Abu-Sbeih H, Thirumurthi S, Mallepally N, Khurana S, Wei D, et al.
Ann Gastroenterol
. 2020 Jan;
33(1):59-67.
PMID: 31892799
Background: Limited data are available concerning the clinical features of toxic gastrointestinal (GI) effects of taxane-based therapy. We describe the clinical, endoscopic and histologic features of taxane-induced colitis. Methods: This...
10.
Abu-Sbeih H, Ali F, Chen E, Mallepally N, Luo W, Lu Y, et al.
Dis Colon Rectum
. 2019 Dec;
63(3):381-388.
PMID: 31842164
Background: Patients undergoing chemotherapy are at risk for mucosal injury and neutropenia, which facilitate colonic mucosal invasion by the bowel flora and subsequent neutropenic enterocolitis, which has a poor prognosis....